In a 38‑year‑old man with isolated adrenocorticotropic hormone deficiency, normal pituitary MRI, no headache, and a history of autoimmune disease (dermatomyositis or systemic lupus erythematosus), how should an elevated insulin‑like growth factor‑1 and mildly elevated prolactin be evaluated and managed?

Evaluation and Management of Elevated IGF-1 and Mildly Elevated Prolactin in Isolated ACTH Deficiency

Immediate Diagnostic Priorities

In a patient with isolated ACTH deficiency and normal pituitary MRI, an IGF-1 of 400 ng/mL with mildly elevated prolactin requires systematic evaluation to exclude acromegaly, assess for evolving hypophysitis, and rule out medication effects or other secondary causes of hyperprolactinemia.

The combination of isolated ACTH deficiency with elevated IGF-1 and prolactin raises three key diagnostic considerations: (1) evolving autoimmune hypophysitis affecting multiple pituitary cell lines, (2) a small pituitary adenoma below MRI detection threshold, or (3) secondary hyperprolactinemia from various causes including the underlying autoimmune condition 1, 2.

Evaluating the Elevated IGF-1

Confirm True Elevation and Assess for Acromegaly

• Repeat IGF-1 measurement with age- and sex-adjusted reference ranges, as a single elevated value requires confirmation before pursuing extensive workup 3.
• If IGF-1 remains elevated, perform an oral glucose tolerance test (OGTT) with growth hormone measurements at 0,30,60,90, and 120 minutes—failure to suppress GH below 1 ng/mL (or 0.4 ng/mL with ultrasensitive assays) confirms acromegaly 3.
• Measure morning fasting GH level; random GH is unreliable due to pulsatile secretion, but persistently elevated fasting GH (>10 ng/mL) supports acromegaly 3.

Clinical Assessment for Acromegaly Features

• Examine for acral enlargement (ring/shoe size changes), frontal bossing, prognathism, macroglossia, skin tags, and sweating 3.
• Screen for acromegaly complications: obtain fasting glucose and HbA1c (diabetes in 30-40%), echocardiogram (cardiac hypertrophy), and colonoscopy if age-appropriate (increased polyp risk) 3.
• Assess for sleep apnea symptoms, as this occurs in 60-80% of acromegaly patients 3.

Consider Non-Acromegaly Causes of Elevated IGF-1

• IGF-1 can be falsely elevated in pregnancy, puberty, obesity, poorly controlled diabetes, liver disease, and with certain medications 3.
• In the context of autoimmune disease (dermatomyositis/SLE), chronic inflammation can occasionally elevate IGF-1 through complex mechanisms 4.

Evaluating the Mildly Elevated Prolactin

Determine Degree of Elevation and Exclude Artifacts

• Prolactin levels 25-100 ng/mL are "mildly elevated" and have a broad differential; levels >200 ng/mL strongly suggest prolactinoma 2, 4.
• Repeat prolactin measurement fasting in the morning to exclude stress-related elevation, and ensure the sample was not drawn through an IV line (can cause spurious elevation) 2.
• Consider macroprolactin assay if prolactin remains persistently elevated without clear cause, as macroprolactin (biologically inactive) accounts for 10-25% of hyperprolactinemia cases 4.

Assess for Medication-Induced Hyperprolactinemia

• Review all medications, particularly antipsychotics, antiemetics (metoclopramide, domperidone), antidepressants (SSRIs, tricyclics), antihypertensives (methyldopa, verapamil), and opioids—these are the most common cause of mild hyperprolactinemia 4.
• Glucocorticoid replacement itself does not cause hyperprolactinemia; however, untreated or undertreated adrenal insufficiency can paradoxically elevate prolactin 5.

Evaluate for Secondary Causes

• Hypothyroidism causes hyperprolactinemia via TRH stimulation of lactotrophs—measure TSH and free T4 simultaneously, as central hypothyroidism may coexist with isolated ACTH deficiency 3, 6, 5.
• Chronic kidney disease (creatinine clearance <50 mL/min) impairs prolactin clearance 4.
• Chest wall lesions, herpes zoster, or breast stimulation can cause hyperprolactinemia via neural pathways 4.

Consider Evolving Autoimmune Hypophysitis

• In a patient with isolated ACTH deficiency and autoimmune disease history, mild hyperprolactinemia may represent "stalk effect" from evolving lymphocytic hypophysitis—pituitary stalk inflammation disrupts dopamine delivery to lactotrophs 2, 7, 5.
• Hyperprolactinemia associated with hypophysitis is typically mild (<100 ng/mL) and may be transient, resolving with glucocorticoid replacement 2, 5.
• The absence of headache does not exclude hypophysitis; approximately 15% of hypophysitis cases present without headache 2.

Comprehensive Pituitary Hormone Assessment

Screen for Additional Pituitary Deficiencies

• Measure morning (8 AM) TSH and free T4 to assess the thyroid axis—low free T4 with low or inappropriately normal TSH indicates central hypothyroidism 3, 1, 6.
• Measure LH, FSH, and testosterone (men) or estradiol (premenopausal women) to evaluate the gonadal axis 2, 4.
• Assess for diabetes insipidus if polyuria or polydipsia is present—measure serum sodium, serum osmolality, and urine osmolality 2.

Critical Safety Point: If central hypothyroidism is confirmed, ensure adequate glucocorticoid replacement for at least one week before initiating levothyroxine, as thyroid hormone increases cortisol metabolism and can precipitate adrenal crisis in untreated adrenal insufficiency 3, 2, 6.

Imaging Reassessment

Repeat Pituitary MRI with Dedicated Protocol

• Obtain a dedicated pituitary MRI with thin cuts (≤3 mm), pre- and post-gadolinium contrast, and coronal and sagittal views to detect microadenomas (<10 mm) that may have been missed on initial imaging 2, 4.
• Assess for pituitary enlargement, stalk thickening, loss of posterior pituitary bright spot, or heterogeneous enhancement—these findings support hypophysitis even when initial MRI was reported as normal 2.
• Approximately 40% of patients with biopsy-proven hypophysitis have normal or near-normal MRI at presentation 2.

Management Algorithm Based on Findings

If Acromegaly is Confirmed (GH Non-Suppression on OGTT)

• Refer to neurosurgery for transsphenoidal resection of GH-secreting adenoma, which is first-line therapy 3.
• If surgery is contraindicated or unsuccessful, initiate medical therapy with somatostatin analogs (octreotide LAR 20 mg IM monthly or lanreotide 90 mg SC monthly) 3.
• Continue hydrocortisone replacement for isolated ACTH deficiency; acromegaly does not reverse adrenal insufficiency 3, 1.

If Prolactinoma is Confirmed (Prolactin >200 ng/mL or Adenoma on MRI)

• Initiate cabergoline 0.25 mg twice weekly, increasing by 0.25 mg twice weekly every 4 weeks based on prolactin levels, up to a maximum of 1 mg twice weekly 8.
• Obtain baseline echocardiogram before starting cabergoline to assess for valvular disease, and repeat periodically during long-term treatment 8.
• After 6 months of normal prolactin levels, consider discontinuing cabergoline with periodic monitoring 8.

If Hypophysitis is Suspected (Mild Hyperprolactinemia, Autoimmune History, Normal/Borderline MRI)

• Optimize hydrocortisone replacement to physiologic doses (15-25 mg daily in divided doses, typically 10 mg at 7 AM, 5 mg at noon, 2.5-5 mg at 4 PM) 1, 2.
• Monitor prolactin every 3-6 months—hyperprolactinemia from hypophysitis often resolves spontaneously with adequate glucocorticoid replacement 2, 5.
• Repeat comprehensive pituitary hormone panel every 6-12 months to detect evolving deficiencies, as hypophysitis can progress from isolated ACTH deficiency to panhypopituitarism 2, 4.
• High-dose glucocorticoids (e.g., prednisone 1 mg/kg) are not indicated for hypophysitis unless there are severe compressive symptoms (visual field defects, rapidly progressive deficits)—physiologic replacement is the cornerstone of management 2.

If All Workup is Negative (Normal OGTT, Mild Prolactin Elevation, No Adenoma)

• Continue hydrocortisone replacement for isolated ACTH deficiency at standard doses 1, 9.
• Recheck prolactin in 3-6 months; if persistently elevated without clear cause, consider empiric trial of cabergoline if symptomatic (galactorrhea, hypogonadism) 8, 4.
• Monitor for development of additional pituitary deficiencies annually with TSH, free T4, LH, FSH, and sex hormones 1, 4.

Common Pitfalls and Caveats

• Do not assume a normal pituitary MRI excludes all pathology—microadenomas <3 mm and early hypophysitis are frequently MRI-negative 2, 4.
• Do not delay glucocorticoid replacement to pursue IGF-1/prolactin workup—untreated adrenal insufficiency is life-threatening and takes priority 1, 9.
• Do not start thyroid hormone before ensuring adequate cortisol replacement—this is a critical error that can precipitate adrenal crisis 3, 2, 6.
• Do not attribute all symptoms to isolated ACTH deficiency—fatigue, weight changes, and nausea can reflect undertreated adrenal insufficiency, evolving hypothyroidism, or acromegaly 3, 1, 4.
• Do not overlook medication review—many commonly prescribed drugs cause hyperprolactinemia and can confound the diagnostic picture 4.
• Do not use random GH levels to diagnose acromegaly—GH is pulsatile and requires suppression testing (OGTT) or IGF-1 for diagnosis 3.

Patient Education and Safety Measures

• Ensure the patient wears a medical alert bracelet indicating adrenal insufficiency and carries a steroid emergency card 1, 2.
• Provide an emergency injectable hydrocortisone 100 mg IM kit with self-injection training for use during vomiting, severe illness, or inability to take oral medications 1, 2.
• Instruct the patient to double or triple hydrocortisone dose during febrile illness, gastroenteritis, or significant physical stress 1, 2.
• Educate on warning signs of adrenal crisis (severe weakness, confusion, hypotension, persistent vomiting) and the need for immediate emergency care 1, 2.